NNovo Nordisk Read More Novo Nordisk’s Oral Wegovy Surpasses $300 Million in Q1 as Global Launch Looms2026-05-07 Novo Nordisk’s oral Wegovy smashed Q1 sales forecasts at $330M, with 2M prescriptions. Global launch begins H2 2026…